jueves, 19 de noviembre de 2026
Yale study explores why arthritis returns after cancer immunotherapy
https://www.news-medical.net/news/20261118/Yale-study-explores-why-arthritis-returns-after-cancer-immunotherapy.aspx
When arthritis develops during cancer immunotherapy, swollen hands can make it hard to open a jar or turn a doorknob. Inflammation in the knees can make walking difficult. For some patients, the joint pain and swelling ease, only to return.
These subsequent flares can be severe enough to interrupt cancer immunotherapy, according to Sang Taek Kim, MD, PhD, assistant professor of medicine (rheumatology, allergy & immunology) at Yale School of Medicine, who notes that approximately 20% to 25% of cancer patients will have rheumatological adverse events after receiving immunotherapy. To better understand why the inflammation recurs, he and his colleagues examined what changed inside the joints between initial and subsequent flares.
In their study, published in Cancer Immunology Research, the team found that some groups of immune cells present during the first flare had become numerous by the second flare. The pattern suggests that during the second occurrence of inflammatory arthritis, the immune system may be drawing on its memory of the earlier response.
“When our immune system encounters the same antigens, those responses can get stronger,” explains Kim, who directs the Yale Immunotherapy Adverse Events in Rheumatology Program.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario